Direct Link:
1862-8354/asset/olbannerleft.jpg?v=1&s=47a2691c51f9d6e6d83bcad52a29869e7c0a62ec)
Editorial
You have free access to this content
Continued Growth in Clinical Proteomics
Article first published online: 22 JAN 2013
DOI: 10.1002/prca.201370014
© 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Issue
PROTEOMICS - Clinical Applications
Special Issue: REVIEWS 2013
Volume 7, Issue 1-2, pages 1–2, January 2013
Additional Information
How to Cite
(2013), Continued Growth in Clinical Proteomics. Prot. Clin. Appl., 7: 1–2. doi: 10.1002/prca.201370014
Publication History
- Issue published online: 22 JAN 2013
- Article first published online: 22 JAN 2013
References
- 1, Viewpoints in clinical proteomics: When will proteomics deliver clinically useful information? Proteomics Clin. Appl. 2012, 6, 343–345.
- 2, Using lectins in biomarker research: Addressing the limitations of sensitivity and availability. Proteomics Clin. Appl. 2012, 6, 346–350.Direct Link:
- 3, How to get proteomics to the clinic? Issues in clinical proteomics, exemplified by CE-MS. Proteomics Clin. Appl. 2012, 6, 437–442.Direct Link:
- 4, A call for a fresh new look at the plasma proteome. Proteomics Clin. Appl. 2012, 6, 443–446.Direct Link:
- 5, Considerations on selected reaction monitoring experiments: Implications for the selectivity and accuracy of measurements. Proteomics Clin. Appl. 2012, 6, 609–614.Direct Link:
- 6, The variability in tissue proteomics. Proteomics Clin. Appl. 2012, 6, 340–342.Direct Link: